IBCCES is the global leader in training and certification for healthcare professionals, educators and corporate partners who work with individuals with autism and other cognitive disorders. Our reach extends to more than 2 million people in all 50 states and over 70 countries around the globe. IBCCES Member Learning Community is provided as a free service to all IBCCES members who have completed one or more of our training and certification programs.
Magic Mushroom Ingredient Could Treat Depression
This post was originally published on this siteLatest Depression News
FRIDAY, Dec. 13, 2019 (HealthDay News) — The active ingredient in magic mushrooms may offer a new treatment for depression, according to researchers.
Results from the phase I study in the U.K. indicate that the ingredient, called psilocybin, could be effective in treating depression in patients who’ve failed to respond to other medications, CNN reported.
The study, conducted by King’s College London and mental healthcare company Compass Pathways, included 89 healthy adults who received 10mg and 25mg doses of psilocybin.
They had “changes in sensory perception and positive mood alteration,” according to a Compass Pathways news release, CNN reported.
The results from U.K. researchers were presented at the annual meeting of the American College of Neuropsychopharmacology.
“The results of the study are clinically reassuring and support further development of psilocybin as a treatment for patients with mental health problems that haven’t improved with conventional therapy, such as treatment resistant depression,” co-lead researcher James Rucker, King’s College London, said in the news release.
A phase II trial will include more than 200 patients with depression across Europe and North America, CNN reported.
Copyright © 2019 HealthDay. All rights reserved.
